Matches in Wikidata for { <http://www.wikidata.org/entity/Q37819140> ?p ?o ?g. }
Showing items 1 to 89 of
89
with 100 items per page.
- Q37819140 description "article científic" @default.
- Q37819140 description "article scientifique" @default.
- Q37819140 description "articolo scientifico" @default.
- Q37819140 description "artigo científico" @default.
- Q37819140 description "artículu científicu espublizáu en 2010" @default.
- Q37819140 description "bilimsel makale" @default.
- Q37819140 description "scientific article published on 13 December 2010" @default.
- Q37819140 description "vedecký článok" @default.
- Q37819140 description "vetenskaplig artikel" @default.
- Q37819140 description "videnskabelig artikel" @default.
- Q37819140 description "vědecký článek" @default.
- Q37819140 description "wetenschappelijk artikel" @default.
- Q37819140 description "wissenschaftlicher Artikel" @default.
- Q37819140 description "наукова стаття, опублікована в грудні 2010" @default.
- Q37819140 description "научни чланак" @default.
- Q37819140 description "գիտական հոդված հրատարակված 2010 թվականի դեկտեմբերի 13-ին" @default.
- Q37819140 description "مقالة علمية نشرت في 13 ديسمبر 2010" @default.
- Q37819140 name "Risk/benefit profile of bevacizumab in metastatic colon cancer: a systematic review and meta-analysis." @default.
- Q37819140 name "Risk/benefit profile of bevacizumab in metastatic colon cancer: a systematic review and meta-analysis." @default.
- Q37819140 name "Risk/benefit profile of bevacizumab in metastatic colon cancer: a systematic review and meta-analysis." @default.
- Q37819140 type Item @default.
- Q37819140 label "Risk/benefit profile of bevacizumab in metastatic colon cancer: a systematic review and meta-analysis." @default.
- Q37819140 label "Risk/benefit profile of bevacizumab in metastatic colon cancer: a systematic review and meta-analysis." @default.
- Q37819140 label "Risk/benefit profile of bevacizumab in metastatic colon cancer: a systematic review and meta-analysis." @default.
- Q37819140 prefLabel "Risk/benefit profile of bevacizumab in metastatic colon cancer: a systematic review and meta-analysis." @default.
- Q37819140 prefLabel "Risk/benefit profile of bevacizumab in metastatic colon cancer: a systematic review and meta-analysis." @default.
- Q37819140 prefLabel "Risk/benefit profile of bevacizumab in metastatic colon cancer: a systematic review and meta-analysis." @default.
- Q37819140 P1433 Q37819140-D576B259-476F-4F73-AEA1-DF794B84D974 @default.
- Q37819140 P1476 Q37819140-B94D19F6-CC39-45DB-BEB5-5105CA0045FE @default.
- Q37819140 P2093 Q37819140-0B5FC0B6-F695-4FE8-B49C-10B58809CBA8 @default.
- Q37819140 P2093 Q37819140-2EDC80E6-A6D0-4829-A052-5C4E6686E41D @default.
- Q37819140 P2093 Q37819140-3420F1BE-AD69-4772-AF65-203EE005E9A3 @default.
- Q37819140 P2093 Q37819140-3D4655B1-703D-496B-95A7-57716407BFDF @default.
- Q37819140 P2093 Q37819140-49B1E4B8-4218-4567-8B99-CE3C9E7BFCDF @default.
- Q37819140 P2093 Q37819140-8074627C-E929-4661-8362-199CA278426F @default.
- Q37819140 P2093 Q37819140-86503430-BC0C-4A35-9618-59CBDE8921F4 @default.
- Q37819140 P2093 Q37819140-A56FA56F-BA8D-4F03-94A8-82F830CCE847 @default.
- Q37819140 P2093 Q37819140-B56BE29F-55B4-422F-B1C9-34B245F99B5A @default.
- Q37819140 P2093 Q37819140-CA8C4016-563C-424C-A452-1AB6EB623918 @default.
- Q37819140 P2093 Q37819140-CB5E10BD-F8D9-42D1-8129-4A179BD95624 @default.
- Q37819140 P304 Q37819140-843BCC52-DEFC-4A18-B878-DCD9A1B99013 @default.
- Q37819140 P31 Q37819140-DF8CC9B0-9136-4999-98D0-6EC144916588 @default.
- Q37819140 P31 Q37819140-eae1b848-e827-449d-b3a8-7d6b33ff122c @default.
- Q37819140 P31 Q37819140-eb68b364-8412-4b38-bfda-13cd4d3930c4 @default.
- Q37819140 P356 Q37819140-07A78775-B52E-4472-A733-6624122203CB @default.
- Q37819140 P433 Q37819140-DA5EAC3A-BED1-4929-9CF8-2EDEE9FDBF6A @default.
- Q37819140 P478 Q37819140-70115434-F79C-4E2A-9071-4807F9D5375F @default.
- Q37819140 P50 Q37819140-12163D73-38D5-42FC-9589-FE6D3688F6F8 @default.
- Q37819140 P50 Q37819140-80AF5602-7DAE-46E0-BCB5-8712B8D2D39A @default.
- Q37819140 P50 Q37819140-9A60040B-9675-453D-A359-143B5E766227 @default.
- Q37819140 P577 Q37819140-C2973398-908A-472E-8BC8-244F57803011 @default.
- Q37819140 P698 Q37819140-2067EA69-8B30-4D97-8A55-F271F8405A0E @default.
- Q37819140 P921 Q37819140-310571CE-27EE-4445-896D-CCE980C6F80C @default.
- Q37819140 P921 Q37819140-36E0248D-6D61-4AA7-AD06-516243ADDC37 @default.
- Q37819140 P921 Q37819140-6DC84584-A06E-474A-973E-525DB00F928C @default.
- Q37819140 P921 Q37819140-C2D0CB54-8798-4E06-B52F-A632D9709617 @default.
- Q37819140 P921 Q37819140-D76CEA9D-1FF0-4BD8-893C-27E513C96DE1 @default.
- Q37819140 P356 J.DLD.2010.10.010 @default.
- Q37819140 P698 21146479 @default.
- Q37819140 P1433 Q15766194 @default.
- Q37819140 P1476 "Risk/benefit profile of bevacizumab in metastatic colon cancer: a systematic review and meta-analysis" @default.
- Q37819140 P2093 "Andrea Manazza" @default.
- Q37819140 P2093 "Anna Moretti" @default.
- Q37819140 P2093 "Annalisa Bramati" @default.
- Q37819140 P2093 "Elena Galfrascoli" @default.
- Q37819140 P2093 "Gabriella Farina" @default.
- Q37819140 P2093 "Gaetana Muserra" @default.
- Q37819140 P2093 "Giovanna Damia" @default.
- Q37819140 P2093 "Michela Cinquini" @default.
- Q37819140 P2093 "Nicla La Verde" @default.
- Q37819140 P2093 "Sheila Piva" @default.
- Q37819140 P2093 "Valter Torri" @default.
- Q37819140 P304 "286-294" @default.
- Q37819140 P31 Q13442814 @default.
- Q37819140 P31 Q7318358 @default.
- Q37819140 P31 Q815382 @default.
- Q37819140 P356 "10.1016/J.DLD.2010.10.010" @default.
- Q37819140 P433 "4" @default.
- Q37819140 P478 "43" @default.
- Q37819140 P50 Q37829909 @default.
- Q37819140 P50 Q56850319 @default.
- Q37819140 P50 Q82827511 @default.
- Q37819140 P577 "2010-12-13T00:00:00Z" @default.
- Q37819140 P698 "21146479" @default.
- Q37819140 P921 Q108566365 @default.
- Q37819140 P921 Q1504425 @default.
- Q37819140 P921 Q18555025 @default.
- Q37819140 P921 Q413299 @default.
- Q37819140 P921 Q815382 @default.